Stay updated on CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.3 has been added to the study history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedA new revision (v3.3.2) was added, replacing the previous v3.3.1, which appears to be a minor update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed from the Study Record History.SummaryDifference0.1%

- Check56 days agoChange DetectedThe government funding status notice has been removed from the page, where it previously warned about funding-related delays and provided links to cc.nih.gov and opm.gov.SummaryDifference0.7%

- Check70 days agoChange DetectedA new entry appears in the Study Record Versions list indicating an updated record version; the rest of the page content remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference12%

Stay in the know with updates to CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.